Accès ouvert déclaré 2025 preprint

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Dale W. Garsed, Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey, Céline M. Laumont, Catherine J. Kennedy, Adelyn Bolithon, Nicola S. Meagher, Katy Milne, Phineas T. Hamilton, Jennifer Alsop, Antonis C. Antoniou, George Au‐Yeung, Matthias W. Beckmann, Amy Berrington de González, Christiani Bisinotto, Freya Blome, Clara Bodelón, Jessica Boros, Alison H. Brand, Michael E. Carney, Alicia Cazorla, Derek S. Chiu, Elizabeth L. Christie, Anita Chudecka-Głaz, Penny Coulson, Kara L. Cushing‐Haugen, Cezary Cybulski, Kathleen M. Darcy, C. W. Mabey David, Trent Davidson, Arif B. Ekici, Esther Elishaev, Julius Emons, Tobias Engler, Rhonda Farrell, Anna Fischer, Montserrat García‐Closas, Aleksandra Gentry-Maharaj, Prafull Ghatage, Rosalind Glasspool, Philipp Harter, Andreas D. Hartkopf, Arndt Hartmann, Sebastian Heikaus, Brenda Y. Hernandez, Anusha Hettiaratchi, Sabine Heublein, David G. Huntsman, Mercedes Jimenez-Linan, Michael E. Jones, Eunyoung Kang, Ewa Kaznowska, Tomasz Kluz, F. Kommoss, Gottfried E. Konecny, Diether Lambrechts, Cheng‐Han Lee, Jenny Lester, Samuel Leung, Yee Leung, Anna Linder, Jolanta Lissowska, Liselore Loverix, Jan Lubiński, Constantina Mateoiu, Iain A. McNeish, Malak Moubarak, Gregg Nelson, Nikilyn Nevins, Alexander Olawaiye, Siel Olbrecht, Sandra Oršulić, Ana Osório, Carmel M. Quinn, Ganendra Raj Mohan, Isabelle Ray‐Coquard, Cristina Rodríguez‐Antona, Patricia Roxburgh, Matthias Ruebner, Stuart Salfinger, Spinder Samra, Minouk J. Schoemaker, Hans‐Peter Sinn, Gabe S. Sonke, Linda Steele, Colin J.R. Stewart, Aline Talhouk, Adeline Tan, Christopher M. Tarney, Sarah E. Taylor, Koen Van de Vijver, Maaike AVan Der Aa, Toon Van Gorp, Els Van Nieuwenhuysen, Lilian van Wagensveld, Andrea E. Wahner-Hendrickson, Christina B. Walter, Chen Wang, Julia Welz, Nicolas Wentzensen, Lynne R. Wilkens, Stacey J. Winham, Boris Winterhoff, Michael S. Anglesio, Andrew Berchuck, Francisco José Cândido dos Reis, Paul A. Cohen, Thomas P. Conrads, Philip Crowe, Jennifer A. Doherty, Peter A. Fasching, Renée T. Fortner, María J. García, Simon A. Gayther, Marc T. Goodman, Jacek Gronwald, Holly R. Harris, Florian Heitz, Hugo M. Horlings, Beth Y. Karlan, Linda E. Kelemen, G. Larry Maxwell, Usha Menon, Francesmary Modugno, Susan L. Neuhausen, Joellen M. Schildkraut, Annette Staebler, Karin Sundfeldt, Anthony Swedlow, Ignace Vergote, Anna H. Wu, James D. Brenton, Paul D.P. Pharoah, Celeste Leigh Pearce, M. C. Pike, Ellen L. Goode, Susan J. Ramus, Martin Köbel, Brad H. Nelson, Anna DeFazio, Michael Friedländer, David D.L. Bowtell

0Citations signalées, ce qui n’est pas une note de qualité

89Institutions déclarées

18Pays d’affiliation déclarés

Rattachement africain : au, us, gb, ca, de, ch, br, es, pl, Afrique du Sud, fi, kr, in, nl, be, se, hu, fr. Niveau de preuve : code pays fourni par la source.

Résumé indisponible. Les résultats de l’étude ne doivent pas être déduits de son seul titre.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref: Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Date Crossref: 03/10/2025
Éditeur: Springer Science and Business Media LLC
Type: posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Peter MacCallum Cancer Centre Breast Cancer Research Foundation University of Arizona Cancer Center Keele University UNSW Sydney Cancer Institute of New South Wales University of British Columbia University of Cambridge Universitätsklinikum Erlangen Breast Center United States Department of Health and Human Services Universidade de São Paulo Clinics Hospital of Ribeirão Preto University of Tübingen American Cancer Society Westmead Institute for Medical Research Westmead Hospital Cancer Center of Hawaii Hospital Universitario Fundación Jiménez Díaz Pomeranian Medical University Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa Fred Hutch Cancer Center Walter Reed National Military Medical Center Royal Hospital for Women Prince of Wales Hospital University of Pittsburgh Comprehensive Cancer Center Erlangen The University of Sydney Institute for Reproductive Health University of Calgary Beatson West of Scotland Cancer Centre Kliniken Essen-Mitte University of Hawaiʻi at Mānoa University of Hawaii System Specim (Finland)Mark Wainwright Analytical Centre Heidelberg University University Hospital Heidelberg Addenbrooke's Hospital Huntsman (United States)Seoul National University Bundang Hospital Institute of Medical Sciences University of Rzeszów University of California, Los Angeles Maastricht University KU Leuven University of Alberta Vancouver General Hospital King Edward Memorial Hospital Sahlgrenska University Hospital National Institute of Oncology The Maria Sklodowska-Curie National Research Institute of Oncology Gynecologic Oncology Group University of Gothenburg Imperial College London Universidad Autónoma de Madrid Centre Léon Bérard Centre for Biomedical Network Research on Rare Diseases University of Glasgow Friedrich-Alexander-Universität Erlangen-Nürnberg St John of God Subiaco Hospital The Netherlands Cancer Institute City of Hope Beckman Research Institute The University of Western Australia Ghent University Hospital Netherlands Comprehensive Cancer Organisation VIB-KU Leuven Center for Cancer Biology Mayo Clinic in Arizona WinnMed University of Hawaii Cancer Center University of Minnesota Duke Medical Center Huntsman Cancer Institute German Cancer Research Center Instituto de Investigaciones Biomédicas Sols-Morreale The University of Texas at San Antonio Health Science Center CS Communication & Systèmes (France)North Carolina Division of Public Health Inova Health System University College London Emory University University of Southern California California Southern University Cancer Research UK Cedars-Sinai Medical Center University of Michigan University of South Wales U-M Rogel Cancer Center

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

PARP inhibition in cancer therapyBRCA gene mutations in cancerOvarian cancer diagnosis and treatment

Lire en accès ouvert Consulter la publication primaire Ouvrir le DOI